Osteogenesis imperfecta (OI) causes hearing loss because the same collagen defect that makes bones fragile throughout the body also damages the tiny bones and structures inside the ear. Roughly 30 to 60% of people with OI develop some degree of hearing loss, and the type of hearing loss often shifts as they age, starting as a conductive problem in younger adults and adding a nerve-related component over time.
How Collagen Affects the Ear
OI is fundamentally a collagen disorder. Type I collagen is the main structural protein in bone, and the ear relies heavily on bone to transmit and process sound. The middle ear contains the three smallest bones in the body: the malleus, incus, and stapes. These bones form a chain that carries vibrations from the eardrum to the fluid-filled inner ear. The inner ear itself sits inside a dense shell of bone called the otic capsule. When the collagen that builds and maintains all of these structures is defective, problems develop at multiple points along the hearing pathway.
Conductive Hearing Loss: The Stapes Problem
The most common ear finding in OI is damage to the stapes, the stirrup-shaped bone that presses against the oval window of the inner ear. In OI, the footplate of the stapes (the flat part that contacts the inner ear) thickens, sometimes doubling to around 2 mm, and eventually becomes fixed in place. The legs of the stapes can also fracture or become so thin they lose structural continuity. When the stapes can no longer vibrate freely, sound transmission from the middle ear to the inner ear drops significantly.
This looks similar to otosclerosis, a more common condition where abnormal bone growth locks the stapes in place. But in OI, the underlying problem is different. Rather than localized bone overgrowth, OI produces brittle, porous bone that accumulates microcracks. Those microcracks trigger disorganized bone repair, leading to thickening and fixation. Surgeons operating on OI ears also frequently encounter excessive bleeding from a thickened lining of the middle ear cavity, broken or paper-thin stapes legs, and bone that crumbles unpredictably. These complications make the surgery considerably harder than standard stapes procedures for otosclerosis.
Conductive hearing loss tends to appear first, typically showing up in patients between their twenties and thirties. In one German study, no patients under 20 had measurable hearing loss, while 7% of those aged 20 to 30 did, and all of those cases were purely conductive.
Sensorineural Hearing Loss: Damage Inside the Cochlea
As people with OI get older, many develop sensorineural hearing loss on top of the conductive component, creating what audiologists call mixed hearing loss. This nerve-related hearing loss comes from damage inside the cochlea, the snail-shaped organ that converts sound vibrations into electrical signals for the brain.
The cochlea sits within the otic capsule, and in OI that bony shell undergoes significant changes. CT imaging shows areas of demineralization (hypodense spots) around the cochlea in about 82% of OI ears, compared to 53% of ears with standard otosclerosis. More importantly, OI tends to affect multiple sites around the cochlea simultaneously, while otosclerosis typically stays more localized. These patches of weakened, porous bone alter the mechanical and chemical environment surrounding the cochlea.
Inside the cochlea, the consequences are concrete. Studies of OI ears have found atrophy and deterioration of the stria vascularis, a tissue layer that maintains the chemical balance the cochlea needs to generate electrical signals. Hair cells, the sensory receptors that detect sound vibrations, also degenerate. Microfractures in the otic capsule, distortion of the tectorial membrane (a gel-like structure that sits above the hair cells), and even small hemorrhages into the fluid spaces of the inner ear have all been documented. Some investigators have also found sclerotic thickening and partial ossification of the cochlea’s basal turn, the region responsible for processing high-frequency sounds.
This explains why some studies report that sensorineural hearing loss in OI begins with a characteristic drop in the 6,000 to 8,000 Hz range, the highest frequencies most audiograms measure. Over time, the loss can spread to lower frequencies.
How Hearing Loss Differs Across OI Types
Not everyone with OI experiences hearing loss in the same way. People with milder OI (type I) appear to be at higher risk overall, with studies reporting hearing loss in 32 to 58% of this group. Those with moderate to severe OI (types III and IV) show hearing loss in 21 to 27% of cases, possibly because other health priorities dominate or because the collagen mutations involved affect the ear differently.
Conductive hearing loss tends to appear first in younger patients with OI type IV, while sensorineural and mixed hearing loss are more common in older patients with OI type I. When sensorineural hearing loss shows up in children, it is almost exclusively found in type I OI. Mixed hearing loss, combining both conductive and nerve-related components, is the most common pattern overall in adults.
Treatment Options and Their Limitations
For conductive hearing loss, stapes surgery (stapedotomy) is an option, but it carries more risk and lower success rates than the same procedure for otosclerosis. A meta-analysis of published results found a success rate of about 59% in OI, compared to 90 to 95% for typical otosclerosis cases. The fragile, bleeding-prone bone in OI makes surgery technically demanding, and revision surgeries are needed more often. Closure of the air-bone gap to 10 decibels or less, the standard benchmark for success, is achieved in a median of 67% of OI cases versus over 90% in otosclerosis.
When hearing loss is too severe or complex for stapes surgery, other devices can help. Cochlear implants have been successfully placed in most reported OI cases (10 out of 11 in one review), though surgeons sometimes encounter excessive bone growth or difficulty identifying key landmarks because of abnormal bone formation. Bone-anchored hearing aids, which bypass the middle ear entirely by transmitting sound vibrations through the skull, have also been used successfully. Across cochlear implants, bone-anchored devices, and other implantable aids, only 2 out of 16 reviewed cases were unsuccessful.
Monitoring Hearing Over Time
Because hearing loss in OI is progressive and can develop without obvious symptoms in its early stages, regular audiometric testing matters. A 2023 expert consensus recommended hearing tests at least every 5 years for people with OI who have no confirmed hearing loss, and at least annually for those who do. Early detection of conductive changes can open a window for intervention before nerve-related damage compounds the problem, and tracking changes over time helps guide decisions about hearing aids, surgery, or implantable devices.